<?xml version="1.0" encoding="UTF-8"?>
<p id="Par37">PrEP efficacy trials indicate that cases of acquisition of ARV resistance are infrequent, predominately limited to individuals receiving PrEP around the time of HIV seroconversion. Furthermore, prolonged PrEP use after HIV infection also promotes acquisition of resistance [
 <xref ref-type="bibr" rid="CR10">10</xref>, 
 <xref ref-type="bibr" rid="CR11">11</xref>]. This is due either to infrequent follow-up or poor performance of available HIV rapid tests in the setting of PrEP use [
 <xref ref-type="bibr" rid="CR12">12</xref>, 
 <xref ref-type="bibr" rid="CR13">13</xref>]. Failure to detect HIV infection using third generation rapid tests has been previously reported and resulted in continued PrEP use in eight cases [
 <xref ref-type="bibr" rid="CR14">14</xref>]. This finding emphasizes the importance of careful HIV screening especially in the setting of wider oral PrEP scale-up in HIV endemic settings where PrEP-related resistance may limit options for subsequent ART.
</p>
